跳至主要内容
临床试验/JPRN-UMIN000005815
JPRN-UMIN000005815已完成未知

Efficacy of selective estrogen receptor modulator in pegylated interferon alpha plus ribavirin treatment for menopausal women with chronic hepatitis C women - Selective estrogen receptor modulator in pegylated interferon alpha plus ribavirin treatment

Department of General Internal Medicine, Kyushu University Hospital0 个研究点目标入组 120 人开始时间: 2011年6月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • Exclusion criteria for the study were: (1) positivity for antibody to human immunodeficiency virus or positivity for hepatitis B surface antigen; (2) clinical or biochemical evidence of hepatic decompensation; (3) excessive active alcohol consumption (> 60 g/day converted into ethanol) or drug abuse; (4) suspected hepatocellular carcinoma at entry; or (5) treatment with antiviral or immunosuppressive agents prior to enrollment.

研究者

发起方
Department of General Internal Medicine, Kyushu University Hospital

相似试验